Key result
Total costs of cardiovascular diseases in Poland from 2015 to 2017 ranged from 34.9 billion to over 40.9 billion PLN, with indirect costs accounting for 84% of the financial burden.
Why the study?
Cardiovascular diseases are associated with growing healthcare expenditures, making accurate estimation of overall societal costs necessary.
Cardiovascular diseases impose a massive financial burden in Poland, with indirect costs accounting for the vast majority (84%) of the total economic impact.
Underscores indirect costs as dominant Polish CVD burden; leaves open targeted interventions to curb productivity losses.
BACKGROUND: Cardiovascular diseases are associated with growing public and private expenditure on healthcare regardless geographic region. Therefore, it is necessary to accurately estimate the overall societal costs-both direct and indirect expenses from the perspective of patients, caregivers and employers. RESEARCH DESIGN: The aim of this paper is to determine the direct and indirect costs related to cardiovascular diseases in Poland from 2015 to 2017. All costs are estimated based on data available in the public domain and obtained from the major Polish institutions. Indirect costs were calculated using a modified human capital approach. RESULTS: The financial burden of cardiovascular diseases in Poland is significant. This study revealed that total costs (direct and indirect) of cardiovascular diseases, for 2015-2017, range from 34.9 bn PLN (8.2 bn EUR) to over 40.9 bn PLN (9.6 bn EUR). Total direct cost and indirect costs were approximately 6.1 bn PLN (1.4 bn EUR) (16%) and 31.3 bn PLN (7.3 bn EUR) (84%), respectively. CONCLUSION: Collectively, the estimated direct and indirect cost of cardiovascular diseases provide a useful input for economic impact assessments of public health programs and health technology analyses.
No takes yet. Share an insight, caveat, or question.
Mela et al. (2020) studied Cardiovascular diseases. Cardiovascular diseases was evaluated on Total direct and indirect costs. Total costs of cardiovascular diseases in Poland from 2015 to 2017 ranged from 34.9 billion to over 40.9 billion PLN, with indirect costs accounting for 84% of the financial burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: